Novel mixed cancer-cell models designed to capture inter-patient tumor heterogeneity for accurate evaluation of drug combinations.

Summary: Every cancer patient is different, which makes finding the right cure very hard. Right now, scientists test new drugs on simple cancer cells in the lab. But these simple cells do not act like the complex tumors found in real people. Because of this, many drugs that work in the lab fail when given to patients.

To fix this, scientists created a new "mixed-cell" model. They mixed different types of prostate cancer cells together to copy real-life tumors. When they tested drugs on this new mix, the results perfectly matched what actually happens in patients! This new tool will help doctors find better drug combinations and save more lives.